• BSE
  • NSE
Partner with US Open an Demat Account EIPO Portfolio Tracker Watsapp Play Store App Store

News Details

29/05/2026 22:30

Indo US Bio-Tech Q4 net profit down 46.47% at Rs 1.97 cr

The company reported standalone net profit of Rs 1.97 crore for the quarter ended March 31, 2026 as compared to Rs 3.68 crore in the same period last year, registering a year-on-year decline of 46.47 per cent.

Net revenue of the company declined substantially by 22.05 per cent at Rs 26.02 crore in January-March quarter of this fiscal as against Rs 33.38 crore in the corresponding period last year.

During January-March quarter, operating expenses dropped by 20.83 per cent to Rs 22.80 crore from Rs 28.80 crore in year ago period.

Other Income dipped by 83.33 per cent at Rs 0.02 crore versus (Mar'25 Rs 0.12 crore).

Operating Profit slipped by 29.48 per cent to Rs 3.23 crore as against Rs 4.58 crore in the year ago period, while Operating Profit Margin (OPM) contracted year-on-year to 9.69 per cent in March quarter.

Interest grew by 130.77 per cent y-o-y to Rs 0.60 crore, while Taxation increased by 115.79 per cent at Rs 0.41 crore (Mar'25 Rs 0.19 crore).